A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

Status:
Unknown status

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Open label, parallel-group, single site, 5 treatment-period study with 4 dose levels of DCCR, 1 of which is administered both with and without food.

Phase 2

Essentialis, Inc.

Choline
Diazoxide